| metastatic/advanced OC (mOC) - 2nd line (L2) | metastatic/advanced OC (mOC) - maintenance (M) | |
| metastatic/advanced OC (mOC) - 2nd line (L2) | metastatic/advanced OC (mOC) - maintenance (M) | |
| avelumab based treatment | ||
| avelumab alone | JAVELIN ovarian 200 ... | |
| avelumab plus pegylated liposomal doxorubicin | JAVELIN ovarian 200 ... | |
| avelumab plus SoC | JAVELIN Ovarian 100 |
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
